Healios K.K.
HLOSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | 362.8% | 34.4% | 119.5% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 77.1% | 89.3% | 100% | 100% |
| R&D Expenses | $2 | $2 | $4 | $4 |
| G&A Expenses | $1 | $1 | $1 | $2 |
| SG&A Expenses | $1 | $1 | $1 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | -$0 | $0 | $0 |
| Operating Expenses | $3 | $3 | $5 | $5 |
| Operating Income | -$3 | -$3 | -$5 | -$5 |
| % Margin | -507.7% | -2,792.6% | -5,754.4% | -13,131.7% |
| Other Income/Exp. Net | -$1 | -$0 | -$0 | $1 |
| Pre-Tax Income | -$4 | -$4 | -$5 | -$4 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | -$4 | -$4 | -$5 | -$5 |
| % Margin | -756.3% | -3,159.5% | -5,744.4% | -11,980.5% |
| EPS | -47.87 | -56.22 | -90.69 | -93.4 |
| % Growth | 14.9% | 38% | 2.9% | – |
| EPS Diluted | -47.87 | -56.22 | -90.69 | -93.4 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $2 |
| Interest Expense | $2 | $1 | $1 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$3 | -$5 | -$5 |
| % Margin | -388.4% | -2,229.8% | -5,301.1% | -12,480.5% |